Magazine October 30, 2017, Issue

Letters

(Mike Blake/Reuters)

Price Controls for Health Care?

In “The Price Is Right” (October 16), Peter Laakmann gives much-needed insight into why per capita spending on health care in the U.S., although higher than in other developed countries, is appropriate to our circumstances. However, he does not address why the price of health care is so high in the first place.

As a physician in Kentucky, I am amazed at the disparity between price and cost. A local lab bills the patient $125 for a blood test for which they bill me $4. When the FDA took generic colchicine off the market in 2010 in

NR Editors includes members of the editorial staff of the National Review magazine and website.

In This Issue

Articles

Features

Books, Arts & Manners

Sections

Letters

Letters

Price Controls for Health Care? In “The Price Is Right” (October 16), Peter Laakmann gives much-needed insight into why per capita spending on health care in the U.S., although higher than ...
The Week

The Week

‐ Who do you think has a higher IQ — Trump, or someone who chose to work for Trump? ‐ President Trump picked a fight with Senator Bob Corker (R., Tenn.), ...